Study Finds No Link Between Tylenol and Autism

A comprehensive study published this week has found no association between the use of acetaminophen, commonly known as Tylenol, during pregnancy and the development of autism in children. This finding directly refutes claims made by former President Donald Trump and Robert F. Kennedy Jr. in September 2023, who asserted a link between the medication and autism without providing clear scientific evidence. Trump had publicly advised pregnant individuals to avoid Tylenol and to "tough it out" through fever and pain.

Medical organizations widely condemned Trump's statements, emphasizing that acetaminophen is considered a safe option for pain and fever management during pregnancy. They also highlighted that untreated fevers in pregnant individuals are known to increase the risk of adverse outcomes, including autism, miscarriage, birth defects, and premature birth. Despite these warnings from the medical community, Trump's message appeared to influence public behavior and legal actions.

Following the former President's remarks, Texas initiated a lawsuit against the manufacturer of Tylenol based on the alleged connection. Furthermore, research published in The Lancet in March indicated a measurable impact on medication use, with a 10 percent decrease in pregnant patients receiving acetaminophen in emergency departments after Trump's press conference. This new study adds to a growing body of scientific evidence that debunks the asserted link between Tylenol and autism.